SCHEMBL8869153

SCHEMBL8869153

CC(C)C(=O)OCCNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)C3CCCCC3)cc2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.52
TSHR P16473 3/20 0.52
LMNA P02545 3/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
BLM P54132 2/20 0.52
HTR1A P08908 1/20 0.52
NFKB1 P19838 1/20 0.52
CNR1 P21554 1/20 0.52
ADRA1A P35348 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
ABCC8 Q09428 2/20 0.42
ALDH1A1 P00352 2/20 0.42
PPARG P37231 2/20 0.42
ABCC3 O15438 1/20 0.42
ABCC4 O15439 1/20 0.42
ABCC9 O60706 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868905 0.92 MAPT (0.53) MAPTTSHRLMNACYP3A4CYP2C9
SCHEMBL8869656 0.91 MAPT (0.56) MAPTTSHRLMNACYP3A4CYP2C9
SCHEMBL7868035 0.89 MAPT (0.43) MAPTTSHRLMNACYP3A4CYP2C9
SCHEMBL8868870 0.89 LMNA (0.49) MAPTTSHRLMNACYP3A4CYP2C9
SCHEMBL8869573 0.88 MAPT (0.56) MAPTTSHRLMNACYP3A4CYP2C9
SCHEMBL8868310 0.87 P4HTM (0.45) MAPTTSHRLMNACYP3A4CYP2C9
SCHEMBL9137083 0.86 TSHR (0.51) MAPTTSHRLMNACYP3A4CYP2C9
SCHEMBL8869180 0.86 TSHR (0.50) MAPTTSHRLMNACYP3A4CYP2C9
SCHEMBL8867649 0.85 MAPT (0.53) MAPTTSHRLMNACYP3A4CYP2C9
SCHEMBL9141318 0.85 MAPT (0.54) MAPTTSHRLMNACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed